Sponsor Pipeline

European Group for Research In Schizophrenia Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07084831 A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After… Schizophrenia; Psychosis Not Yet Recruiting
Disease Areas
Schizophrenia (1)
Get alerts when European Group for Research In Schizophrenia's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free